SCHEDULE OF MILESTONES PAYMENT (Details) |
12 Months Ended |
|---|---|
|
Mar. 31, 2026
USD ($)
| |
| Phase I Human Clinical Trial [member] | |
| IfrsStatementLineItems [Line Items] | |
| Amount of licensed product or service | $ 300,000 |
| Phase II Human Clinical Trial [member] | |
| IfrsStatementLineItems [Line Items] | |
| Amount of licensed product or service | 600,000 |
| Phase III Human Clinical Trial [member] | |
| IfrsStatementLineItems [Line Items] | |
| Amount of licensed product or service | $ 1,500,000 |